Detalhe da pesquisa
1.
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease.
N Engl J Med;
386(3): 230-240, 2022 01 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34767321
2.
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.
N Engl J Med;
387(11): 978-988, 2022 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36036525
3.
Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases.
Clin Proteomics;
19(1): 7, 2022 Mar 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35317720
4.
The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation.
Am Heart J;
225: 69-77, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32474206
5.
Refining Risk Stratification Among Children With Latent Rheumatic Heart Disease.
Circulation;
147(24): 1848-1850, 2023 06 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37307310
6.
Latent Rheumatic Heart Disease: Identifying the Children at Highest Risk of Unfavorable Outcome.
Circulation;
136(23): 2233-2244, 2017 Dec 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28972003
7.
Prevalence and characteristics of primary left-sided valve disease in a cohort of 15,000 patients undergoing echocardiography studies in a tertiary hospital in Uganda.
BMC Cardiovasc Disord;
18(1): 82, 2018 05 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29728065
8.
Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study).
Circulation;
134(19): 1456-1466, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27702773
9.
Noonan syndrome in diverse populations.
Am J Med Genet A;
173(9): 2323-2334, 2017 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28748642
10.
Prevalence of group a streptococcus pharyngeal carriage and clinical manifestations in school children aged 5-15 yrs in Wakiso District, Uganda.
BMC Infect Dis;
17(1): 248, 2017 04 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28381239
11.
Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation.
BMC Cardiovasc Disord;
17(1): 20, 2017 01 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28061759
12.
Wasting, underweight and stunting among children with congenital heart disease presenting at Mulago hospital, Uganda.
BMC Pediatr;
17(1): 10, 2017 01 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28077108
13.
Cardiac strain findings in children with latent rheumatic heart disease detected by echocardiographic screening.
Cardiol Young;
27(6): 1180-1185, 2017 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28088920
14.
Child and teacher acceptability of school-based echocardiographic screening for rheumatic heart disease in Uganda.
Cardiol Young;
27(1): 82-89, 2017 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26983378
15.
The Impact of Echocardiographic Screening for Rheumatic Heart Disease on Patient Quality of Life.
J Pediatr;
175: 123-9, 2016 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27268786
16.
Prevalence of arrhythmias among children below 15 years of age with congenital heart diseases attending Mulago National Referral Hospital, Uganda.
BMC Cardiovasc Disord;
16: 67, 2016 Apr 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27074797
17.
Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study).
Eur Heart J;
36(18): 1115-22a, 2015 May 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25425448
18.
The Uganda Heart Association.
Eur Heart J;
40(29): 2396-2397, 2019 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31539909
19.
Latent rheumatic heart disease: outcomes 2 years after echocardiographic detection.
Pediatr Cardiol;
35(7): 1259-67, 2014 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24827080
20.
Quality of Life in Ugandan Children and Young Adults After Surgery for Congenital Heart Disease: Mixed Methods Approach.
Glob Heart;
19(1): 36, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38638125